+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Osteoarthritis Drug"

From
Osteoarthritis Market Report 2025 - Product Thumbnail Image

Osteoarthritis Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Osteoarthritis Therapeutics Market Report 2025 - Product Thumbnail Image

Osteoarthritis Therapeutics Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
From
Osteoarthritis - Pipeline Insight, 2025 - Product Thumbnail Image

Osteoarthritis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 280 Pages
  • Global
From
Knee Osteoarthritis - Pipeline Insight, 2025 - Product Thumbnail Image

Knee Osteoarthritis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
Erosive Hand Osteoarthritis - Pipeline Insight, 2025 - Product Thumbnail Image

Erosive Hand Osteoarthritis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Arthrogryposis Global Market Report 2025 - Product Thumbnail Image

Arthrogryposis Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
From
From
Osteoarthritis Therapeutics: Global Markets 2021-2026 - Product Thumbnail Image

Osteoarthritis Therapeutics: Global Markets 2021-2026

  • Report
  • January 2022
  • 133 Pages
  • Global
From
Loading Indicator

The Osteoarthritis Drug market is a subset of the larger Musculoskeletal Disorders Drugs market. Osteoarthritis is a degenerative joint disease that affects millions of people worldwide. It is characterized by the breakdown of cartilage in the joints, leading to pain, stiffness, and decreased mobility. Treatment for osteoarthritis typically involves a combination of lifestyle changes, physical therapy, and medications. Common medications used to treat osteoarthritis include non-steroidal anti-inflammatory drugs (NSAIDs), analgesics, and disease-modifying antirheumatic drugs (DMARDs). The Osteoarthritis Drug market is highly competitive, with a variety of companies offering products to treat the condition. Some of the major players in the market include Pfizer, Merck, Novartis, AbbVie, and Johnson & Johnson. Other companies such as Amgen, Eli Lilly, and Bristol-Myers Squibb also offer products for the treatment of osteoarthritis. Show Less Read more